Relife
Relife is a B2B medical aesthetics brand and Menarini Group subsidiary that sells the Definisse™ portfolio of threads, fillers, peels, hydration injectables, and bio-peptide collagen modulators to licensed aesthetic practitioners across eight European and Asian markets.
- Company typePrivate
- Founded2016
- HeadquartersRungis, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Relife does
Relife is a B2B medical aesthetics company that operates as a brand within the Menarini pharmaceutical group, with its corporate seat at Menarini France in Rungis, France. The company sells a multi-modality portfolio of medical aesthetic products under the Definisse™ brand to licensed healthcare professionals and aesthetic clinics — principally dermatologists, plastic surgeons, and aesthetic practitioners — across France, Italy, Germany, Austria, Thailand, Ireland, the United Kingdom, and Benelux. Its core product families include Definisse™ Threads (tissue support threads for lifting procedures, including Revitalise and 3D Lift variants), Definisse™ Fillers (dermal fillers for volume restoration and wrinkle correction), Definisse™ Rinnova Peel (chemical peels for skin resurfacing), Definisse™ Hydrobooster (injectable hydration), Definisse™ [KP¹]® Bio-Peptide Collagen Modulator (a bio-peptide-based collagen modulator), and the Pigment Solution™ Program for hyperpigmentation. Relife also operates the RELIFE Academy, a training platform for clinicians performing aesthetic procedures.
The company operates an enterprise field sales model, distributing products directly to healthcare professionals through the Menarini regional offices in each market. It runs eight localized websites and a dedicated academy site to support clinician education and brand engagement. Revenue is generated through one-time product sales of regulated medical devices and consumables via prescription/clinical channels; pricing is not publicly disclosed. Relife leverages the parent group's clinical, regulatory, manufacturing, and distribution infrastructure, but does not publish standalone financials, headcount, management roster, funding history, or independent revenue figures. As a brand subsidiary within a larger pharmaceutical company, Relife's strategic positioning is shaped by Menarini's broader medical aesthetics and pharmaceutical operations rather than by independent capital allocation.
Relife firmographics
Firmographics- Name
- Relife
- Legal name
- Relife
- Website
- https://relifecompany.fr
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Relife is a B2B medical aesthetics brand and Menarini Group subsidiary that sells the Definisse™ portfolio of threads, fillers, peels, hydration injectables, and bio-peptide collagen modulators to licensed aesthetic practitioners across eight European and Asian markets.
- Ownership category
- akta.pro rank
Relife industry classification
Industry- Product category
- Medical Aesthetics
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)
- akta.pro secondary industries
- Professional Skincare & Facial Treatments (CRABALAF), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where Relife is headquartered
LocationHeadquarters
- HQ city
- Rungis
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Relife business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D
Revenue model
- Medical Aesthetic Products: Relife generates revenue through the sale of medical aesthetic products including tissue support threads, dermal fillers, chemical peels, and bio-peptide treatments to healthcare professionals and aesthetic clinics.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Relife product offering
Product offeringCore offering
Relife develops and sells a portfolio of medical aesthetic products under the Definisse™ brand, including tissue support threads, dermal fillers, chemical peels, hydration boosters, and bio-peptide collagen modulators. These products are sold to licensed healthcare professionals — dermatologists, plastic surgeons, and aesthetic practitioners — through Menarini's regional office network in Europe and Asia. The company also operates the RELIFE Academy to train practitioners on aesthetic treatment techniques.
Product overview
Relife is an aesthetic medicine company offering a portfolio of aesthetic products under the Definisse™ brand family. The product line includes Definisse™ Threads (tissue support threads for lifting procedures), Definisse™ Fillers (dermal fillers for volume restoration), Definisse™ Rinnova Peel (chemical peel treatment), Definisse™ Hydrobooster (hydrating injectable), Definisse™ [KP¹]® Bio-Peptide Modulateur de Collagène (collagen-supporting bio-peptide), and the Pigment Solution™ Program (pigmentation treatment). The company also operates RELIFE Academy for training and education in aesthetic procedures. Relife is part of the Menarini Group (MENARINI FRANCE).
Differentiator
Problem solved
Functional benefit
Brands
- Definisse™ Threads: Fils de soutien tissulaire (tissue support threads)
- Definisse™ Fillers
- Definisse™ Rinnova Peel
- Definisse™ Hydrobooster
- Definisse [KP¹]® Bio-Peptide Modulateur de Collagène
- Pigment Solutions™ Program
- RELIFE Academy
Products and services
- Definisse™ Threads
- Definisse™ [KP¹]® Bio-Peptide Modulateur de Collagène
- Pigment Solution™ Program
- Definisse™ Fillers
- Definisse™ Rinnova Peel
- Definisse™ Hydrobooster
Companies that use Relife
Customer profileSegments1 record
Ideal customer profiles1 record
Relife technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Relife partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Menarini GroupcoreRelife is a brand under the Menarini pharmaceutical group. Menarini provides corporate infrastructure, distribution networks, and manufacturing capabilities for Relife aesthetic products across international markets.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
Relife competitors and assessment
Company assessmentDirect peers
- Sinclair Pharma: Sinclair Pharma is a close direct peer with a portfolio of aesthetic medicine products including threads, hyaluronic acid fillers, and bio-stimulators sold to aesthetic practitioners — a near-mirror of Relife's Definisse™ portfolio.
- Teoxane: Teoxane is a Swiss aesthetics company specializing in hyaluronic acid dermal fillers and skin boosters, directly competing with Relife's Definisse Fillers and Hydrobooster in the injectables category.
- IBSA Derma: IBSA Derma markets Profhilo and other bio-remodeling hyaluronic acid injectables, directly competing in the injectable skin quality and hydration category where Relife's Hydrobooster and KP1 bio-peptide compete.
- Croma-Pharma: Croma-Pharma manufactures and distributes a portfolio of hyaluronic acid fillers, PDO threads, and biostimulators — overlapping squarely with Relife's product mix across threads, fillers, and regenerative aesthetics.
- Aptos (threads): Aptos is a pioneer and direct competitor in the thread lift category, marketing PDO/PLLA lifting threads — directly competing with Relife's Definisse Threads (Revitalise and 3D Lift) across aesthetic clinics.
Emerging players
- Hugel: Hugel is a Korean aesthetics company with botulinum toxin (Letybo/Botulax), fillers, and bio-stimulators. It is expanding globally from an emerging-market base and competes with Relife in injectable aesthetics.
- Revance Therapeutics: Revance is a US-based aesthetics company with neuromodulators and the RHA dermal filler line, positioning as a science-driven emerging player in the injectable aesthetics market where Relife competes.
Broad incumbents
- Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie division, markets leading brands including Botox, Juvederm fillers, CoolSculpting, and skin care — a dominant incumbent whose scale, clinical evidence, and marketing reach dwarf Relife's footprint.
- Merz Aesthetics: Merz Aesthetics is a major global aesthetics player offering fillers (Belotero), toxins (Xeomin), and devices — a broad incumbent whose portfolio breadth and physician training compete with Relife's narrow but focused offering.
- Galderma: Galderma is one of the largest pure-play dermatology and aesthetics companies globally, with Restylane fillers, Sculptra bio-stimulator, and a broad aesthetics portfolio — a clear incumbent competing in nearly all of Relife's categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Relife social profiles
Digital presenceRelife financial estimates
Financial estimateRevenue estimate
Valuation estimate
Relife leadership team
Management profileNumber of profiles
Relife funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Relife M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Relife
What does Relife do?
Relife develops and sells a portfolio of medical aesthetic products under the Definisse™ brand, including tissue support threads, dermal fillers, chemical peels, hydration boosters, and bio-peptide collagen modulators. These products are sold to licensed healthcare professionals — dermatologists, plastic surgeons, and aesthetic practitioners — through Menarini's regional office network in Europe and Asia. The company also operates the RELIFE Academy to train practitioners on aesthetic treatment techniques.
Is Relife a public or private company?
Relife is a private company. It is classified as corporate owned and is currently operating.
When was Relife founded?
Relife was founded in 2016. It employs 11 to 50 people.
Where is Relife based?
Relife is headquartered in Rungis, France, in the Europe region.
How does Relife make money?
One revenue line is on record: medical Aesthetic Products.
Who are Relife's main competitors?
Direct peers on record are Sinclair Pharma, Teoxane, IBSA Derma, Croma-Pharma and Aptos (threads). Emerging players are Hugel and Revance Therapeutics. Broad incumbents are Allergan Aesthetics (AbbVie), Merz Aesthetics and Galderma.
Does Relife have an API?
No public API is recorded for Relife.
What industry is Relife in?
Relife's product category is Medical Aesthetics. Its primary akta.pro industry code is HLAKACAE, Cosmetic Dermatology (Aesthetic Injectables), with a secondary code of CRABALAF, Professional Skincare & Facial Treatments. Its NAICS code is 339113 and its SIC code is 2844.